ArticleScientific reports2025

The use of angiotensin-converting enzyme inhibitors in hospitalized patients with COVID-19 is associated with a lower risk of mortality.

Mykola Khalangot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.